Clinical Trials Logo

Clinical Trial Summary

antiperistaltic effect and safety of L-menthol versus placebo for upper GI endoscopy in elderly patient with contraindication to Buscopan: randomized study


Clinical Trial Description

Endoscopy is a important tool for diagnosis and treatment of gastrointestinal diseases. Effective inhibition of gastrointestinal motility during examination is important to achieve good results and quality. Traditionally, hyoscine-N-butylbromide (Buscopan) is the most commonly used drugs that inhibit intestinal peristalsis. But the side effects of drugs were mentioned in many studies, such as arrhythmia, increased glaucoma, dysuria in patients who have benign prostatic hypertrophy and allergic reactions, and may even cause anaphylactic shock. Peppermint oil is the extract of the natural plant (Mentha X piperita L) which was growth in North America and Europe. L-menthol is main component of peppermint oil. In animal experiments, peppermint oil had effect of calcium channel blockers and cause gastrointestinal smooth muscle relaxing effect. Clinically, peppermint oil preparations were used to relieve stress headache, non-ulcer dyspepsia and irritable bowel syndrome. The oral or intestinal local spraying of peppermint oil or L-menthol showed inhibition of intestinal peristalsis in many studies, and improved colonoscopy, barium enema, retrograde cholangiography , and upper gastrointestinal endoscopy examination. With the aging of the population of Taiwan and the universality of endoscopy for elderly patients, the safety of endoscopy in elderly patients has more and more attention. According to ASGA guidelines, age is not a contraindication for endoscopy. But 50% of elderly patients have contraindications for hyoscine-N-butylbromide use. Therefore, effort to find alternative medicine to improve quality of endoscopy in elderly patients is necessary. Therefore, the investigators design a research for comparing effect and safety of L-menthol and placebo in elderly patients who have contraindication of hyoscine-N-butylbromide. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04593836
Study type Interventional
Source Taipei Veterans General Hospital, Taiwan
Contact Ming-Chih Hou, MD
Phone 886-2-28712121
Email mchou@vghtpe.gov.tw
Status Recruiting
Phase Phase 3
Start date March 2012
Completion date December 2020

See also
  Status Clinical Trial Phase
Completed NCT02863861 - Sedation for Upper Gastrointestinal Endoscopy in Pediatric Patients Phase 4
Completed NCT03280784 - Clinical Audit on the Use of Upper Endoscopy in Assist University Children Hospital
Recruiting NCT06220175 - Pharynx Analgesia Before Upper Gastrointestinal Endoscopy N/A
Recruiting NCT06218537 - The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy N/A
Completed NCT01471600 - Safety and Efficacy of Carbohydrate Drink Ingested Two Hours Before Upper Endoscopy Under General Anaesthesia N/A